NEJM Study Finds Pfizer’s Paxlovid Does ‘Little or Nothing’ for COVID-19

Study: Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 https://www.nejm.org/doi/full/10.1056/NEJMoa2309003 “Kind of shocking a drug that costs $1,300…is showing in a randomized controlled trial to not really relieve COVID symptoms. That’s a lot of money for something that provenly doesn’t work it seems.” https://www.youtube.com/watch?v=HM27ulOyG9Q